Lupin plans to build new pharma manufacturing plant in Coral Springs
Coral Springs: Global pharmaceutical company, Lupin, has announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in Coral Springs.
With a projected cumulative investment of $250 million, including research & development, infrastructure and capital expenditures over a five-year period, the new site will have the capacity to accommodate the production of more than 25 critical respiratory medicines, including lifesaving albuterol inhalers for children with asthma and service members at home and overseas.
By strengthening domestic manufacturing and enhancing supply chain diversification, this project will enhance medicine security and strengthen Lupin’s position as a global respiratory leader. Locally, this will generate over 200 new long-term, skilled jobs by 2030 in Broward County.
“The expansion of Lupin’s footprint in Coral Springs is a core part of our growth strategy. This new state-of-the-art facility will build on our existing presence in Florida, which is home to Lupin’s headquarters and our Advanced Inhalation Research Center. This investment demonstrates Lupin’s commitment to innovation, quality and supply chain reliability — and our ability to partner with Florida’s leaders to strengthen America’s medicine security by growing our capacity to produce affordable treatments for patients. We are grateful to Florida’s leadership for their partnership in making this possible,” said Christoph Funke, Chief Technical Operations Officer, Lupin.
“On behalf of FloridaCommerce, I’m excited to welcome Lupin’s expansion in Coral Springs and the high-impact investment it brings to our state,” said Florida Secretary of Commerce J. Alex Kelly. “Thanks to Governor DeSantis’ leadership, Florida has built a strong foundation for growth—with a strong focus on research and development, nine consecutive years as the #1 state for postsecondary education and three consecutive years as the #1 state for talent development, Florida has become #2 in the nation for both pharmaceutical and medical device manufacturing. Lupin’s investment will strengthen Florida’s position as a leader in life sciences, boost our advanced manufacturing capabilities and enhance the state’s medicine security—delivering long-term benefits to both our economy and the health of Floridians.”
